Authors
Loading...
Randomized trial developed a decision instrument for chemotherapy preference in breast cancer patients, suggesting effective communication of risks.
Levine et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: